Bacterial
multidrug efflux pumps have come to prominence in human
and veterinary pathogenesis because they help bacteria protect themselves
against the antimicrobials used to overcome their infections. However,
it is increasingly realized that many, probably most, such pumps have
physiological roles that are distinct from protection of bacteria
against antimicrobials administered by humans. Here we undertake a
broad survey of the proteins involved, allied to detailed examples
of their evolution, energetics, structures, chemical recognition,
and molecular mechanisms, together with the experimental strategies
that enable rapid and economical progress in understanding their true
physiological roles. Once these roles are established, the knowledge
can be harnessed to design more effective drugs, improve existing
microbial production of drugs for clinical practice and of feedstocks
for commercial exploitation, and even develop more sustainable biological
processes that avoid, for example, utilization of petroleum.